Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non-muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013. [electronic resource]
Producer: 20160411Description: 256-62 p. digitalISSN:- 1873-7560
- Administration, Intravesical
- Adult
- Aged
- Aged, 80 and over
- Ambulatory Care
- Antineoplastic Agents -- administration & dosage
- BCG Vaccine -- administration & dosage
- Carcinoma -- drug therapy
- Chi-Square Distribution
- Disease Progression
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Humans
- Induction Chemotherapy
- Kaplan-Meier Estimate
- Maintenance Chemotherapy
- Male
- Middle Aged
- Multivariate Analysis
- Risk Factors
- Spain
- Time Factors
- Treatment Outcome
- Urinary Bladder Neoplasms -- drug therapy
- Urothelium -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.